In mid-January 2018, Carillion, the UK’s second largest construction company that provides business support services as well as public services in schools, prisons, hospitals, transportation systems, and ministry of defense sites, announced that it was forced into compulsory liquidation. Carillion, which has debts and liabilities totaling roughly US $3 billion, stated that the company was unable to secure funding to continue its business plan.
The situation could also have a significant impact on other prominent companies who partnered with Carillion in on-going projects, small businesses that serve as Carillion’s subcontractors, and even Carillion’s competitors. Some sources estimate that Carillion has outstanding bills totaling nearly US $1.6 billion with various subcontractors, a circumstance that has created some uncertainty in the market.
Knowing more about your partners before you start doing business with them is essential. Smith Brandon offers Due Diligence services to help you see potential problems before you partner with a company. You may also simply want to know how an event like this, may effect your business, or you may want to be sure you know about big changes in industries before you enter a new market. Smith Brandon International’s Business Intelligence and Political Risk Assessments can help you stay ahead of problems in the markets you want to enter.
What Others Are Saying
“Excellent report as always. We truly found it extremely helpful.”
DirectorEuropean Hotel Group
“As always, perfect. The client on the project in Taiwan was most pleased.”
“...you definitely helped [our division] and the whole company improve ... so [we] can make better informed decisions regarding our strategy.”
Strategy DirectorMajor Infrastructure Firm
“The reporting you just furnished us has helped us avoid a major mistake in looking at the potential new partner ... we are very pleased.”
VP for ComplianceInternational Construction Company
“Many thanks for your reporting and willingness to talk with us about what it means. You are correct, we do have an issue and we will take corrective action immediately.”
Corporate CounselInternational Pharmaceutical Company